Tg Therapeutics (TGTX) Other Non Operating Income (2011 - 2026)
Tg Therapeutics (TGTX) recorded Other Non Operating Income of $5.13 million in Q2 2026, up 83.7% from $2.79 million a year earlier.
Powered by 
Analysis
Tg Therapeutics (TGTX) Other Non Operating Income (2011 - 2026) Analysis & Trends
On a TTM basis, Tg Therapeutics' Other Non Operating Income came in at $376,000 as of Jun 30, 2026, down 96.8% year-over-year; for FY2025, it came in at $10.79 million, up 40.3% from FY2024.
- Annual Other Non Operating Income has increased for four straight years, with a four-year compound annual growth rate of 47.1% (FY2021 to FY2025).
- Across earlier years, Other Non Operating Income came in at $7.69 million in FY2024 (+52.5%), $5.04 million in FY2023 (+7.4%), $4.7 million in FY2022 (+103.5%) and $2.31 million in FY2021.
- The Q2 2026 figure is the highest quarterly Other Non Operating Income in data going back to Q2 2011.
- On a year-over-year basis, Other Non Operating Income rose in five of the last seven quarters, with growth averaging 86.3%.
- Peak year-over-year performance for Other Non Operating Income in the last five years was growth of 309.4% in Q1 2025, against a decline of 55.9% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at -$9.15 million (Q1 2026), $1.13 million (Q4 2025) and $3.27 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Tg Therapeutics | 8.31 Bn | 7.70 Bn | 199.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.13 Mn |
| Mar 31, 2026 | -9.15 Mn |
| Dec 31, 2025 | 1.13 Mn |
| Sep 30, 2025 | 3.27 Mn |
| Jun 30, 2025 | 2.79 Mn |
| Mar 31, 2025 | 3.60 Mn |
| Dec 31, 2024 | 2.57 Mn |
| Sep 30, 2024 | 2.67 Mn |
| Jun 30, 2024 | 1.71 Mn |
| Mar 31, 2024 | 880,000.00 |
| Dec 31, 2023 | 890,000.00 |
| Sep 30, 2023 | 2.86 Mn |
| Jun 30, 2023 | 691,000.00 |
| Mar 31, 2023 | 604,000.00 |
| Dec 31, 2022 | 1.93 Mn |
| Sep 30, 2022 | 793,000.00 |
| Sep 30, 2011 | -2.10 Mn |
| Jun 30, 2011 | -2.23 Mn |
API Access
Tg Therapeutics Other Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=TGTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-operating-income", "ticker": "TGTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=TGTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();